Evidence map›Paper›PMID 38603271›Full record

ArticleThe international journal of high performance computing applications2023

Free energy perturbation-based large-scale virtual screening for effective drug discovery against COVID-19.

Zhe Li, Chengkun Wu, Yishui Li, Runduo Liu, Kai Lu, Ruibo Wang, Jie Liu, Chunye Gong, Canqun Yang, Xin Wang and 2 more

Open access · greenAbstract read
In one paragraph

Article in The international journal of high performance computing applications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Fighting COVID-19 with HPC.Nature computational science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Zhe LiSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P. R. China.ORCID https://orcid.org/0000-0002-9357-6839
Chengkun WuState Key Laboratory of High Performance Computing, Changsha, P. R. China.ORCID https://orcid.org/0000-0002-9688-5311
Yishui LiState Key Laboratory of High Performance Computing, Changsha, P. R. China.
Runduo LiuSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P. R. China.ORCID https://orcid.org/0000-0002-8446-0404
Kai LuState Key Laboratory of High Performance Computing, Changsha, P. R. China.
Ruibo WangState Key Laboratory of High Performance Computing, Changsha, P. R. China.
Jie LiuState Key Laboratory of High Performance Computing, Changsha, P. R. China.
Chunye GongState Key Laboratory of High Performance Computing, Changsha, P. R. China.
Canqun YangNational Supercomputer Center in Tianjin, Tianjin, P. R. China.
Xin WangSchool of Medicine and Pharmacy, Ocean University of China, Qingdao, P. R. China.
Chang-Guo ZhanMolecular Modeling and Biopharmaceutical Center, College of Pharmacy, University of Kentucky, Lexington, KY, USA.
Hai-Bin LuoSchool of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, P. R. China.
Sun Yat-sen University · CNMarine Biomedical Research Institute of Qingdao · CNNational Supercomputing Center of Tianjin · CNUniversity of Kentucky · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a theoretically rigorous and accurate method, FEP-ABFE (Free Energy Perturbation-Absolute Binding Free Energy) calculations showed great potential in drug discovery, but its practical application was difficult due to high computational cost. To rapidly discover antiviral drugs targeting SARS-CoV-2 M

Indexed as

absolute binding free energyfree energy perturbationSARS-CoV-2Supercomputingvirtual screening

Identifiers

PMID38603271
PMCPMC9396747
OpenAlexW4292596061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.